E83.52
Hypercalcemia
Clinical Classification Guidelines
Inclusion Terms
- Familial hypocalciuric hypercalcemia
Medical Intelligence & Overview
Hypercalcemia refers to an elevated level of calcium in the blood. Calcium plays a key role in various bodily functions, including bone health, nerve transmission, and muscle function. When calcium levels become too high, it can disrupt these processes and potentially lead to health complications. One specific type of hypercalcemia is familial hypocalciuric hypercalcemia (FHH), a genetic condition characterized by elevated blood calcium levels with low calcium excretion in the urine.
Causes & Symptoms
Clinical Causes: Genetic factors, such as familial hypocalciuric hypercalcemia (FHH) Primary hyperparathyroidism Malignancies that produce parathyroid hormone-related protein (PTHrP) Vitamin D intoxication or overuse Granulomatous diseases like sarcoidosis or tuberculosis Certain medications, including thiazide diuretics prolonged immobilization Other endocrine disorders
Key Symptoms: Muscle weakness or fatigue Frequent thirst and increased urination Nausea, vomiting, or constipation Abdominal pain Bone pain or fractures Confusion, depression, or cognitive disturbances Heart arrhythmias or irregular heartbeat in severe cases Sometimes, no noticeable symptoms are present especially in mild cases
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves measuring blood calcium levels through serum tests. To differentiate familial hypocalciuric hypercalcemia from other causes like primary hyperparathyroidism, urine tests are performed to assess calcium excretion. Genetic testing can confirm the specific mutation associated with familial hypocalciuric hypercalcemia. Additional tests may include assessing parathyroid hormone (PTH) levels, kidney function, and other relevant markers to understand the underlying cause.
Treatment Protocols: Treatment approaches depend on the severity and underlying cause of hypercalcemia. In familial hypocalciuric hypercalcemia, usually no treatment is necessary as the condition is benign and does not cause symptoms or health problems. For other causes, managing hypercalcemia may involve hydration therapy, medications such as bisphosphonates, or surgical removal of overactive parathyroid glands if hyperparathyroidism is diagnosed. Monitoring calcium levels regularly is important to prevent complications while avoiding unnecessary treatment in benign cases.
Clinical Advice & FAQs
Billing Guidance
Is E83.52 a billable ICD-10 code?
Yes, E83.52 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E83.52?
Clinical documentation must specify the nature of Hypercalcemia and any associated comorbidities for accurate reporting.
Cite this Clinical Reference